Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
23,450
+450 (1.96%)
At close: Nov 26, 2025
46.11%
Market Cap163.42B
Revenue (ttm)66.51B
Net Income (ttm)2.32B
Shares Out6.97M
EPS (ttm)n/a
PE Ratio70.36
Forward PEn/a
Dividend1,000.00 (4.42%)
Ex-Dividend DateDec 29, 2025
Volume11,507
Average Volume27,127
Open23,150
Previous Close23,000
Day's Range22,950 - 23,700
52-Week Range14,500 - 31,450
Beta-0.32
RSI52.56
Earnings DateNov 14, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.